Ticagrelor and Clopidogrel on Reperfusion in Patients With AMI
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 600 participants.
Also called NCT02233790
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 600 participants
- Registry
-
NCT02233790
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT02233790. Randomized; no masking; primary purpose treatment. Start 2014-12 (registry gives no type); primary completion 2016-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Ticagrelor and Clopidogrel on Reperfusion in Patients With AMI
- Condition
- Myocardial Infarction
- Condition
- No-Reflow Phenomenon
- Intervention (Drug)
- Ticagrelor
- Intervention (Drug)
- Clopidogrel
- Lead sponsor
- First Hospital of China Medical University
- Collaborator
- AstraZeneca
Record details
- Record id
cardio:ct-nct02233790- Content hash
5c3e9103f0ed4e4474466967f4240760e949f2b2b3defa1e5a6ab5cc7329db0c